Ticker Details
Thermo Fisher Scientific, Inc. Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$191.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.10 | 0.99%
Avg Daily Range (30 D):	$7.56 | 1.32%
Avg Daily Range (90 D):	$6.16 | 1.08%

Institutional Daily Volume
Avg Daily Volume:	1.84M
Avg Daily Volume (30 D):	2.27M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	31
Avg Trade Size (Sh.) (90 D):	28

Institutional Trades
Total Institutional Trades:	38,227
Avg Institutional Trade:	$11.53M
Avg Institutional Trade (30 D):	$37.94M
Avg Institutional Trade (90 D):	$41.22M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$53.84M
Avg Closing Trade (30 D):	$161.73M
Avg Closing Trade (90 D):	$151.51M
Avg Closing Volume:	167.77K

News

Feb 24, 2026 @ 9:00 AM Global Biopharmaceutical CMO Market Projected to R... Source: Sns Insider

Feb 18, 2026 @ 3:00 PM Clinical Trials Support Software Solutions in a $3... Source: Towards Healthcare

Feb 13, 2026 @ 3:00 PM Decoding Our DNA: The Human Impact Behind SNP Geno... Source: Towards Healthcare

Feb 11, 2026 @ 6:40 PM Bio-Preservation Market to Reach US$ 44.45 Billion... Source: Astute Analytica

Feb 9, 2026 @ 12:15 PM This Top Artificial Intelligence (AI) Stock Could ... Source: John Ballard

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$17.34	$4.28	$4.28
Diluted EPS	$17.31	$4.27	$4.28
Revenue	$43.74B	$11.12B	$10.86B
Gross Profit
Net Income / Loss	$6.58B	$1.62B	$1.62B
Operating Income / Loss	$7.51B	$1.94B	$1.83B
Cost of Revenue
Net Cash Flow	$-2658M	$-2516M	$120M
PE Ratio	29.79